Shanghai OPM Biosciences Hits Day High with 11.76% Surge in Stock Price

Shanghai OPM Biosciences Co. has experienced a significant surge in its stock price, gaining 11.76% on July 10, 2026. The stock reached an intraday high of CNY 49.51, marking a notable performance against the backdrop of a -1.0% decline in the China Shanghai Composite index for the same day. Over the past week, Shanghai OPM Biosciences has shown a robust increase of 9.21%, and its one-month performance stands at an impressive 37.16%. However, the company has faced challenges in the longer term, with a one-year return of 3.64%, which lags behind the broader market's 13.86% gain. Despite these fluctuations, the company reported positive financial metrics, including a net sales figure of CNY 187.85 million for the first half of the year, reflecting a growth rate of 37.97%. Additionally, the operating cash flow reached its highest at CNY 114.81 million, and net profit for the same period was CNY 34.51 million. With a market capitalization of CNY 4,006 million, Shanghai OPM Biosciences continues to navigate a competitive landscape in the pharmaceuticals and biotechnology sector.